Finance

Beta
Lists
TCRX:NASDAQ
Tscan Therapeutics Inc
0,98 $
+0,27%
(+0,0026) 1D
1,00 $
+2,02% (+0,020)
After hours
Closed: 30 հնս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TCRX...
Open
0,97 $
High
1,01 $
Low
0,94 $
Mkt. cap
63,97 մլն
Avg. vol.
546,12 հզր
Volume
1,05 մլն
52-wk high
2,57 $
52-wk low
0,83 $
EPS
-0,96 $
Beta
1,03
Shares outstanding
61,07 մլն
No. of employees
138
Open
0,97 $
High
1,01 $
Low
0,94 $
Mkt. cap
63,97 մլն
Avg. vol.
546,12 հզր
Volume
1,05 մլն
52-wk high
2,57 $
52-wk low
0,83 $
EPS
-0,96 $
Beta
1,03
Shares outstanding
61,07 մլն
No. of employees
138
News stories
From sources across the web
About Tscan Therapeutics Inc
CEO-
Employees138
Founded2018
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitetscan.com
Analyst ratings
Based on 5 analysts giving stock ratings to TCRX in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TCRX in the last 3 months.
Highest
Current 0,98 $
7,00 $ (+614,21%)
Average
6,00 $ (+512,18%)
Lowest
5,00 $ (+410,15%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Nierengarten
Wedbush
Buy
Maintained
5,00 $
+410,2%
06/23/2026
Maxwell Skor
Morgan Stanley
Hold
Maintained
-
-
06/22/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
6,00 $
+512,2%
06/23/2026
Gil Blum
Needham
Buy
Reiterated
6,00 $
+512,2%
06/23/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
7,00 $
+614,2%
06/23/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
3,08 մլն
2,51 մլն
2,57 մլն
982,00 հզր
Cost of goods sold
32,63 մլն
31,69 մլն
18,44 մլն
21,90 մլն
Cost of revenue
32,63 մլն
31,69 մլն
18,44 մլն
21,90 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,10 մլն
7,87 մլն
5,99 մլն
8,22 մլն
Operating expense
9,10 մլն
7,87 մլն
5,99 մլն
8,22 մլն
Total operating expenses
41,73 մլն
39,56 մլն
24,42 մլն
30,12 մլն
Operating income
-38,65 մլն
-37,05 մլն
-21,86 մլն
-29,14 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-36,95 մլն
-35,71 մլն
-22,98 մլն
-28,67 մլն
EBT excluding unusual items
-36,95 մլն
-35,71 մլն
-20,98 մլն
-28,67 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36,95 մլն
-35,71 մլն
-22,98 մլն
-28,67 մլն
Net profit margin
-1 201,30%
-1 422,14%
-895,09%
-2 919,14%
Earnings per share
-0,28
-0,28
-0,18
-0,22
Interest and investment income
2,39 մլն
2,04 մլն
1,58 մլն
1,16 մլն
Interest expense
-689,00 հզր
-699,00 հզր
-702,00 հզր
-689,00 հզր
Net interest expenses
1,70 մլն
1,34 մլն
881,00 հզր
473,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-37,96 մլն
-36,28 մլն
-21,14 մլն
-28,45 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer